CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates how endogenous retroelements (EREs) are repurposed by tumor cells to enhance cancer growth. By mapping ERE transcription and identifying their roles in cancer and immunity, the research aims to uncover new therapeutic targets for cancer treatment.
Exaptation, the co-option of endogenous retroelements (EREs) for new molecular and cellular functions that confer a host fitness advantage, is a major force in evolution, but may also be exploited, through onco-exaptation, by tumour cells to promote the oncogenic process.
There are over 4 million well-recognised and annotated individual ERE integrations in the human genome.
However, their participation at the level of the more complex transcriptome is far less well understood and, therefore, the…
THE FRANCIS CRICK INSTITUTE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
